• Explore /
  • Poster
  • / A phase II trial of panitumumab with irinotecan and S-1 (IRIS) as second-line treatment in patients with wild-type <em>KRAS</em> metastatic colorectal cancer.

A phase II trial of panitumumab with irinotecan and S-1 (IRIS) as second-line treatment in patients with wild-type KRAS metastatic colorectal cancer.

Abstract Poster

Authors

Rai Shimoyama

Rai Shimoyama

Shonan Kamakura General Hospital, Kanagawa, Japan

Rai Shimoyama , Tetsuo Kimura , Toshi Takaoka , Kazuki Sakamoto , Shunji Kawamoto , Koji Yoshizaki , Yuji Negoro , Fuminori Goda , Akihito Tsuji , Tsuyoshi Nakayama , Hiroshi Miyamoto , Tetsuji Takayama , Yoshiro Niitsu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000004659

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 732)

DOI

10.1200/jco.2015.33.3_suppl.732

Abstract #

732

Poster Bd #

E22

Abstract Disclosures

Similar Posters

First Author: M. Peeters

First Author: Daniel H. Ahn

First Author: Zev A. Wainberg

First Author: Zev A. Wainberg